Table 1.
Effect of different levels of gamma-oryzanol and gamma-oryzanol nanoparticles on motility parameters of rooster sperm assessed by CASA after freeze-thawing.
Treatments |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parameters | C | GO20 | GO40 | GO60 | GO80 | GO100 | CN | GO20N | GON40 | GON60 | GON80 | GON100 | SEM |
TM (%) | 37.3e | 40.9de | 43.5de | 52.4c | 60.2b | 39.5e | 38.6e | 43.2de | 47.8cd | 66.3ab | 71.7a | 41.8de | 1.59 |
PM (%) | 16.9d | 17.3cd | 18.2cd | 18.5cd | 22.4bc | 17.2cd | 17.0d | 18.1cd | 19.1cd | 26.8b | 34.9a | 17.3cd | 1.14 |
VAP (µm/s) | 30.5c | 30.7c | 31.1c | 31.8c | 33.1bc | 30.3c | 30.1c | 30.9c | 32.6bc | 36.3ab | 38.2a | 30.1c | 0.88 |
VSL (µm/s) | 16.8c | 17bc | 17.4bc | 18.3bc | 19.1abc | 16.9c | 16.9c | 17.3bc | 18.6bc | 20.9ab | 22.8a | 16.9c | 0.83 |
VCL (µm/s) | 54.2b | 54.4b | 55.2ab | 56.1ab | 57.6ab | 54.3b | 54.3b | 54.8b | 56.9ab | 57.5ab | 60.3a | 54.8b | 1.14 |
LIN (%) | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 1.47 |
STR (%) | 55.4 | 56.1 | 56.3 | 57.7 | 58 | 56 | 56.5 | 56.4 | 57.1 | 58.2 | 59.6 | 56.1 | 3.1 |
BCF (Hz) | 16.2 | 16.4 | 16.7 | 16.9 | 17.1 | 16.4 | 16.3 | 16.8 | 17 | 17.7 | 18.4 | 16.5 | 0.94 |
ALH (µm) | 5.5 | 5.3 | 5.1 | 5 | 4.6 | 5.2 | 5.4 | 5.1 | 4.8 | 4.5 | 4.3 | 5.1 | 0.31 |
Abbreviations: LIN, linearity; PM, progressive motility; TM, total motility; VAP, average path velocity; VCL, curvilinear velocity; VSL, straight-line velocity.
Lake extender including gamma-oryzanol (GO) at 0 (C) (control group), 20 (GO20), 40 (GO40), 60 (GO60), 80 (GO80), and 100 (GO100) µM and gamma-oryzanol nanoparticles (GON) at 0 (CN), 20 (GON20), 40 (GON40), 60 (GO60), 80 (GON80), and 100 (GON100) µM.
Different superscripts within the same row indicate significant differences among groups (P < 0.05).